Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Imetelstat for treating relapsed or refractory intermediate-2 or high-risk myelofibrosis after janus kinase inhibitor treatment	Imlunestrant	Myelofibrosis	Haematological Cancer and Lymphomas , Haematology	2024	View \| Download
Imetelstat for Myelodysplastic syndrome	Imetelstat (GRN163L; JNJ-63935937)	Myelodysplastic syndrome (MDS)	Haematological Cancer and Lymphomas	2020	View \| Download
IMCgp100 for the Treatment of Advanced or Metastatic Uveal Melanoma	IMCgp100 (Tebentafusp)	Uveal melanoma	Oncology	2017	View \| Download
IgPro20 for treating dermatomyositis	IgPro20	Dermatomyositis	Dermatology , Infectious Disease	2024	View \| Download
Idecabtagene vicleucel for treating relapsed or refractory multiple myeloma after 2 therapies	Idecabtagene vicleucel (Ide-cel; bb2121)	Multiple myeloma (MM)	Haematological Cancer and Lymphomas	2022	View \| Download
Idasanutlin in addition to cytarabine for relapsed or refractory acute myeloid leukaemia	Cytarabine , Idasanutlin (RG7388; RO5503781)	Acute myeloid leukaemia (AML)	Haematological Cancer and Lymphomas	2019	View \| Download
IcoSema for treating adults with type 2 diabetes	IcoSema (NN1535)	Type 2 diabetes	Endocrine Nutritional and Metabolic Disorders	2023	View \| Download
Icosapent ethyl for reducing the risk of cardiovascular events	Icosapent ethyl (Miraxion; LAX-101d; AMR-101; Vascepa)	Cardiovascular events	Cardiovascular System	2020	View \| Download
Iclepertin for treating cognitive impairment associated with schizophrenia in people aged 18 to 80 years	Iclepertin (BI 425809)	Schizophrenia	Mental and Behavioural Health	2024	View \| Download
Ibrutinib with Venetoclax and Obinutuzumab for the treatment of Chronic Lymphocytic Leukaemia patients with TP53 deletion and/or mutation	Obinutuzumab (Gazyvaro; RO5072759; GA101; Afutuzumab) , Venetoclax (Venclyxto; ABT-199; Venclexta; GDC-0199)	Chronic lymphocytic leukaemia (CLL)	Haematological Cancer and Lymphomas	2017	View \| Download